Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.

Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.

Show other versions (1)
Saved in:
Bibliographic Details
Online Access: Online Access
Online Access
Corporate Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (Author)
Format: Government Document eBook
Language:English
Published: Washington : U.S. Government Printing Office, 2013.
Subjects:
United States. > Food and Drug Administration > Rules and practice.
Drug approval > United States.
Generic drugs > Government policy > United States.
Biologicals > Government policy > United States.
Drug accessibility > United States.
Fees, Administrative > United States.
Description
Item Description:Title from title screen (viewed on Aug. 14, 2013)
Paper version available for sale by the Superintendent of Documents, U.S. Government Printing Office.
"Serial number 112-114."
Physical Description:1 online resource (iv, 194 pages) : illustrations.
Bibliography:Includes bibliographical references.

Similar Items